scispace - formally typeset
F

Franz Fazekas

Researcher at Medical University of Graz

Publications -  634
Citations -  59050

Franz Fazekas is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Hyperintensity & Stroke. The author has an hindex of 101, co-authored 629 publications receiving 49775 citations. Previous affiliations of Franz Fazekas include Hospital of the University of Pennsylvania & University of Graz.

Papers
More filters
Journal ArticleDOI

Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis

TL;DR: Altered LCN2 regulation in early MS is demonstrated and first evidence for this to be possibly linked to both clinical MS activity and iron accumulation in the basal ganglia is provided.
Journal ArticleDOI

Cerebral hemodynamic changes following treatment with erythropoietin.

TL;DR: It is concluded that the hematologic and rheologic changes following EPO treatment cause CBF and BFV to return toward normal and improve neuropsychologic performance in patients with end-stage renal disease.
Journal ArticleDOI

Intravenous immunoglobulin in MS: Promise or failure?

TL;DR: Trials failed to establish a role for IVIG in the treatment of secondary or primary progressive MS, but most consistent beneficial results with a reduction of relapse rates and a slowing of disability have been obtained in relapsing-remitting MS.
Journal ArticleDOI

Depressive symptoms following herpes simplex encephalitis : an underestimated phenomenon?

TL;DR: Findings suggest a high frequency of depressive symptoms and a low quality of life with respect to mental health following HSE, and patients felt more impaired by affective than by physical symptoms.
Journal ArticleDOI

Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination

TL;DR: The expression pattern of N-cadherin immunoreactivity in experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein (MOG-EAE) allows a detailed evaluation of all stages of de- and remyelination during lesion development.